GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (OTCPK:KDGTF) » Definitions » Revenue

Kindstar Globalgene Technology (Kindstar Globalgene Technology) Revenue : $135.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Revenue?

Kindstar Globalgene Technology's revenue for the six months ended in Dec. 2023 was $66.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $135.3 Mil. Kindstar Globalgene Technology's Revenue per Share for the six months ended in Dec. 2023 was $0.07. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.14.

Warning Sign:

Kindstar Globalgene Technology Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Kindstar Globalgene Technology was -42.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, Kindstar Globalgene Technology's highest 3-Year average Revenue per Share Growth Rate was 37.40% per year. The lowest was -2.20% per year. And the median was 22.80% per year.


Kindstar Globalgene Technology Revenue Historical Data

The historical data trend for Kindstar Globalgene Technology's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Revenue Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 118.74 136.31 146.12 198.89 135.47

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.32 98.50 104.29 68.81 66.46

Competitive Comparison of Kindstar Globalgene Technology's Revenue

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Revenue distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Revenue falls into.



Kindstar Globalgene Technology Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $135.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology  (OTCPK:KDGTF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Kindstar Globalgene Technology Revenue Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology (Kindstar Globalgene Technology) Business Description

Traded in Other Exchanges
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (Kindstar Globalgene Technology) Headlines

No Headlines